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The incidence of oral candidosis has increased in recent years, largely as a result of the emergence of human
immunodeficiency virus infection and the more widespread use of immunosuppressive chemotherapy. This
development has been associated with a need for more reliable methods for the detection of Candida. The
present study assessed the performance of a real-time PCR and two block-based PCRs for the detection of
Candida in 193 concentrated oral rinse culture (CRC) specimens. A total of 102 CRC specimens were positive
by culture for Candida; and 96, 90, and 75 of these were also positive by real-time, N18-specific, and internal
transcribed spacer (ITS)-specific PCRs, respectively. The five false-negative results by the real-time PCR were
all non-Candida albicans positive by culture. Of the 91 culture-negative CRC specimens, 20, 41, and 44 were
positive by the real-time PCR and the N18- and ITS-specific PCRs, respectively. All three PCRs detected fungal
DNA in 8 culture-negative CRC specimens, with a further 30 being positive by two of the three PCRs. A total
of 32 CRC specimens were Candida free by all methods. In summary, a real-time PCR that provides a sensitive,
specific, and rapid alternative technique for detection of Candida in the mouth is described.
The predominant fungi isolated from the human mouth be-
long to the genus Candida, and while there are more than 350
Candida species, approximately 10 of these colonize the oral
cavity. Candida albicans is recognized as the most prevalent
species (70 to 75% of isolates), followed by C. glabrata and C.
tropicalis (7% of isolates) (9, 13). The reported rate of oral
carriage of Candida yeasts among healthy individuals has been
variable but ranges from 35 to 80% (1, 4) and is dependent on
the population studied and the sampling methods used.
Debilitation of an individual can result in the occurrence of
clinical oral candidosis, which may be defined as acute or
chronic pseudomembranous candidosis (oral thrush), acute er-
ythematous candidosis (Candida-associated denture stomati-
tis), chronic erythematous candidosis, or chronic hyperplastic
candidosis (CHC) (3). Previously, host factors that were im-
plicated in the onset of these infections received greater atten-
tion than the virulence factors of Candida. This was reflected in
many diagnostic microbiological laboratories, where the ability
to identify yeast isolates was limited. In recent years there has
been increased interest in oral candidosis, partly due to the
escalation of human immunodeficiency virus infection and
AIDS and the more widespread use of immunosuppressive
chemotherapy. As a consequence, there has been an associated
increased demand for reliable sampling and identification
methods.
Methods for sampling of the mouth for Candida include the
taking of a smear (16), swab (15), or imprint specimen for
culture (2); culture of whole saliva (24); and concentrated oral
rinse culture (CRC) (10, 15). CRC is widely used, and although
it does not directly target specific mucosal lesions, it provides
a measure of the candidal load and can permit detection of
other microbes. Candida levels of 600 CFU/ml of CRC speci-
men have been reported for healthy commensal carriage (10,
11), with higher numbers (2  103 to 3  103 CFU/ml)
evident in individuals with conditions that predispose them to
infection (15). Samaranayake et al. (15) compared CRC with
imprint culture for detection of oral microbes and found that
CRC was superior for yeast detection. They subsequently rec-
ommended the use of CRC as the screening approach for
detecting oral yeast carriage.
One drawback of detection methods based on culture is the
delay before a diagnostic report can be made available to the
clinicians. Primary isolation media are routinely incubated for
48 h at 37°C, followed by a possible 72-h incubation for phys-
iological or biochemical identification (20). The advent of dif-
ferential primary agars, such as CHROMagar Candida
(CHROMagar Ltd., Paris, France) and Albicans ID (Bio-
Me´rieux, Basingstoke, United Kingdom), has enabled the pre-
sumptive identification of certain species (14), although phys-
iological identification is still recommended and is a necessity
for the majority of species. More recently, the introduction of
molecular PCR-based techniques has resulted in the develop-
ment of tests that can potentially detect Candida directly in
oral samples. One such approach, namely, real-time PCR with
the LightCycler instrument (Idaho Technologies, Idaho Falls),
was recently developed for the sensitive (1 to 5 CFU/ml) and
rapid (1-day) detection of seven clinically relevant Candida
species in blood (18).
The aim of the present study was to assess the performance
of this real-time PCR for the detection of Candida species
directly in CRC samples. Originally, the real-time assay was
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developed to detect candidemia, and so it was necessary to
determine the detection limit of the real-time PCR for Can-
dida in spiked CRC samples rather than blood. It was also
essential to establish how effective the real-time assay was for
detection of clinical and commensal populations by direct com-
parisons to the “gold standard” culture and other molecular
approaches.
MATERIALS AND METHODS
Collection of CRC samples and culture. A total of 145 samples for CRC
(Table 1) were taken from patients (49 males, 96 females) attending the Oral
Medicine Clinic of the Dental School, University of Wales College of Medicine,
Cardiff, United Kingdom. As the patients were sampled as part of the routine
mycological diagnostic service, they were suspected of being clinically colonized
with Candida. In addition, a further 48 samples for CRC were obtained from
healthy volunteers (20 males, 28 females) who had no clinical signs of oral
candidosis. The procedure used for CRC sample collection involved rinsing of
the mouth with 10 ml of sterile phosphate-buffered saline (PBS; 0.1 M; pH 7.2),
which was held in the mouth for 1 min prior to collection in a sterile container.
Each rinse was centrifuged (2,000  g; 10 min), the supernatant was removed,
and the deposit was resuspended in 1 ml of PBS. A portion (50 l) of the
concentrate was inoculated onto Sabouraud dextrose agar (Lab M, Bury, United
Kingdom) with a spiral plater system (Don Whitley Scientific, Shipley, United
Kingdom) prior to incubation at 37°C for 48 h. Suspected Candida colonies were
subcultured onto plates of CHROMagar Candida, which were incubated for 48 h
at 37°C for isolation of multiple yeast species. The remaining 950 l of the
sample for CRC was stored at 20°C prior to DNA extraction. Confirmation of
yeast identity was achieved with the API 32C system (BioMe´rieux).
Detection limits of PCR with CRC samples. Ten control strains of Candida
(Table 2) were cultured in yeast nitrogen base medium (Becton Dickinson,
Oxford, United Kingdom) supplemented with 0.5% (wt/vol) glucose for 24 h at
37°C. The resulting yeast growth was harvested by centrifugation, washed three
times in PBS, and enumerated with a hemocytometer counting chamber. Serial
decimal dilutions were prepared in PBS to provide an estimated 106 to 100
yeasts/ml, and these were used to evaluate the sensitivities and the specificities of
the PCRs.
Extraction of DNA from concentrated rinse samples. DNA was extracted from
950 l of CRC concentrate and spiked control samples by use of the QIAamp
DNA Mini kit (Qiagen, Crawley, United Kingdom), as described by White et al.
(18). The extracted DNA was resuspended in 50 l of Tris-EDTA buffer. Por-
tions of this template DNA were then used for PCR (Table 3). Negative controls
of uninoculated PBS were also included for DNA extraction and PCR.
PCR detection of Candida. The real-time PCR assay (18) used panfungal
primers (primers L18F and L18R) to amplify a variable region within the 18S
rRNA gene. The resulting 140-bp product was detected by SYBR Green incor-
poration and hybridization of a cyanine 5-labeled Candida-specific probe (18)
(Fig. 1). One of the block-based PCRs used primers and reaction conditions
previously described for fungal DNA amplification (23); however, the second
block-based PCR used new primers N18F and N18R, which were designed to be
Candida specific (Table 3). The Candida-specific block-based PCR (with primers
N18F and N18R) targeted the 18S rRNA gene and amplified a 620-bp product
spanning the region from 238 to 857 bp in the 18S rRNA gene of C. albicans
(GenBank accession no. M60302.1). The amplicons generated by both block-
based systems were detected by standard agarose gel electrophoresis and
ethidium bromide staining.
TABLE 1. Agreement between culture and PCR for detection of Candida in CRC samplesa
Clinical sign(s) No. ofsamples
No. of samples
positive by culture
% Agreement with culture (no. of samples PCR positive)
Real-time PCR ITS-specific PCR N18-specific PCR
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Lichen planus 19 10 80 (8) 78 (2) 67 (6b) 44 (5) 80 (8) 44 (5)
BMS, sore mouth 48 24 96 (23) 63 (9) 71 (17) 50 (11c) 79 (19) 46 (13)
Angular cheilitis 5 3 100 (3) 50 (1) 67 (2) 0 (2) 100 (3) 0 (2)
Coated tongue 1 0 ND 0 (1) ND 100 (0) ND 0 (1)
Dry mouth 14 11 100 (11) 67 (1) 91 (10) 67 (1) 100 (11) 67 (1)
Leukoplakia 4 4 75 (3) ND 100 (4) ND 100 (4) ND
Ulceration 2 0 ND 100 (0) ND 50 (1) ND 50 (1)
Pemphigoid 2 1 100 (1) 50 (1) 100 (1) 0 (1) 100 (1) 0 (1)
Fissured tongue 1 0 ND 100 (0) ND 0 (1) ND 0 (1)
Perioral dermatitis 1 1 100 (1) ND 100 (1) ND 100 (1) ND
CHC 7 6 100 (6) 100 (0) 83 (5) 100 (0) 67 (4) 0 (1)
PC 14 8 100 (8) 67 (2) 75 (6) 50 (3) 75 (6) 50 (3)
CEC 19 12 83 (10) 100 (0) 50 (6) 57 (3) 100 (12) 57 (3)
AEC 5 4 100 (4) 100 (0) 100 (4) 0 (1) 100 (4) 0 (1)
Previous candidosis 3 1 100 (1) 50 (1) 100 (1) 100 (0) 100 (1) 100 (0)
Healthy mouthsd 48 17 100 (17) 94 (2) 71 (12) 52 (15) 94 (16) 74 (8)
Total 193 102 94 (96) 78 (20) 74 (75) 51 (44) 88 (90) 55 (41)
a Abbreviations: ND, not determined; BMS, burning mouth syndrome; CHC, chronic hyperplastic candidosis; CEC, chronic erythematous candidosis; PC,
pseudomembranous candidosis; AEC, acute erythematous candidosis.
b One isolate not tested.
c Two isolates not tested.
d Clinically healthy oral mucosa with no history of oral candidosis.
TABLE 2. Detection of 10 Candida species in CRC samples
by PCR
Candida species Isolate reference
Lower detection limit
(no. of yeasts/ml) ofa:
Real-time
PCR
ITS-specific
PCR
N18-specific
PCR
C. albicans GDH 2346 100–101 104–105 101–102
C. dubliniensis CD36 NCPF 3949 101–102 104–105 101–102
C. krusei Lab strain 101–102 104–105 101–102
C. viswanathii Lab strain 100–101 105–106 100–101
C. guilliermondii Y02.02 ND 105–106 100–101
C. glabrata Y33.149 102–103 104–105 101–102
C. famata Lab strain ND 103–104 100–101
C. inconspicua Lab strain 104–105 103–104 101–102
C. parapsilosis NCPF 3104 100–101 105–106 101–102
C. tropicalis Lab strain 100–101 104–105 101–102
a The sensitivity of culture is 1 colony in 50 l or 20 CFU/ml of concentrate.
ND, not detected.
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RESULTS
Detection limits of PCR with CRC samples. The limits of
detection of the PCRs were initially assessed to confirm that
the previous methodology used with blood samples was trans-
ferable to CRC samples. Table 2 presents the limits of detec-
tion for the real-time and block-based PCR systems for 10
Candida species. Real-time PCR detected all species except C.
guilliermondii and C. famata. The Candida-specific (N18)
block-based PCR showed good levels of detection that actually
matched those of the real-time PCR for certain species (Table
2 and Fig. 2). The internal transcribed spacer (ITS) block-
based PCR detected a wide range of Candida species but had
consistently lower levels of detection (Table 2).
Culture and PCR detection of Candida in CRC samples. To
compare the performance of the gold standard culture with
those of the molecular methods, a clinical study of samples
from 145 people with from various oral conditions was per-
formed. In addition to this population, samples from a further
48 healthy control people with no symptoms of oral candidosis
were tested to determine the degree of false-positive, clinically
insignificant results generated by each assay.
Candida was detected by culture in 85 (59%) of the 145
clinical CRC samples and in 17 (38%) of the 48 healthy control
CRC samples. Of the 85 clinical CRC samples that were cul-
ture positive, C. albicans was evident in 72 (85%). Other yeasts
detected by culture, either in combination with C. albicans or
alone, were C. glabrata (n  4), C. krusei (n  2), Candida
inconspicua (n 1), Candida spp. (n 15), and Saccharomyces
cerevisiae (n  1). More than one Candida species was de-
tected in 10 of the 85 samples positive by culture. C. albicans
was the only species detected by culture in the 17 positive
healthy control CRC samples.
Real-time PCR demonstrated that 97 (67%) of the 145 clin-
ical CRC samples and 19 (40%) of the 48 healthy control CRC
samples were positive for Candida. The N18-specific block-
based PCR was positive for 109 (75%) clinical CRC samples
and 22 (46%) of the healthy control CRC samples. In compar-
ison, the ITS-specific PCR gave positive results for 93 (64%)
clinical CRC samples and 25 (52%) healthy control CRC sam-
ples.
Table 1 and Fig. 3 present the agreement between Candida
culture and PCR detection of Candida in the CRC samples. By
using culture as the gold standard, the overall sensitivity and
specificity of the real-time PCR were 94 and 78%, respectively,
with only six culture-positive clinical CRC samples being neg-
ative by the real-time PCR. All six were culture negative for C.
albicans. All culture-positive healthy control CRC samples
were positive by real-time PCR.
Compared with the real-time PCR, a lower correlation with
CRC positivity was evident by the block-based PCRs. The
N18-specific PCR achieved a sensitivity and a specificity of 88
and 55%, respectively. By using 95% confidence intervals (12)
it was decided that the difference in sensitivity between the
real-time PCR and the N18-specific PCR was not significant
(95% confidence intervals, 14 to 2%). However, by using the
same statistical method it was shown that the real-time PCR
assay was 11 to 34% (95% confidence intervals) more specific
than the N18-specific PCR. The sensitivity and specificity of
the ITS-specific PCR were 74 and 51%, respectively (Fig. 3),
T
A
B
L
E
3.
Prim
ers
and
conditions
of
specific
PC
R
s
used
in
the
study
Prim
er
or
probe
(sequence)
C
om
ponents
of
PC
R
s a
N
o.of
cycles
D
N
A
denaturation
conditions
Prim
er
annealing
conditions
Prim
er
extension
conditions
IT
S
1
(5-T
T
C
G
T
A
G
G
T
G
A
A
C
C
T
G
C
G
G
-3)
and
IT
S
2
(5-G
C
T
G
C
G
T
T
C
T
T
C
A
T
C
G
A
T
G
C
-3)
1
T
aq
buffer,0.2
m
M
each
dN
T
P,0.5

M
each
prim
er,1.5
m
M
M
gC
l2 ,2.5
U
of
T
aq
polym
erase,5

lof
extracted
D
N
A
(equivalent
to
100

lof
rinse
concentrate)
b
30
95°C
for
1
m
in
55°C
for
1
m
in
72°C
for
2
m
in
N
18F
(5-T
T
T
G
A
T
G
A
T
T
C
A
T
A
A
T
A
A
C
T
T
T
T
)
and
N
18R
(5-C
G
T
C
C
C
T
A
T
T
A
A
T
C
A
T
T
A
C
G
A
T
)
1
PC
R
buffer
(1.5
m
M
M
gC
l2 ),0.2
m
M
each
dN
T
P,0.75

M
each
prim
er,2.5
U
of
T
aq
polym
erase,10

lof
D
N
A
tem
plate
(equivalent
to
200

lof
rinse
concentrate)
b
35
Initialdenaturation
at
94°C
for
5
m
in
94°C
for
1
m
in
55°C
for
1
m
in
72°C
for
1.5
m
in
and
finalcycle
at
72°C
for
7
m
in
L
18F
(5-C
T
C
G
T
A
G
T
T
G
A
A
C
C
T
T
G
G
),L
18R
(5-G
C
C
T
G
C
T
T
T
G
A
A
C
A
C
T
C
T
),and
C
yanine
5-labeled
probe
(T
T
T
T
G
A
T
G
C
G
T
A
C
T
G
G
A
C
C
C
T
G
T
)
5

lL
ight
C
ycler
m
aster
m
ixture
(B
iogene),
0.5

lof
each
prim
er
(finalconcentration,
0.6

M
),0.5

lof
SY
B
R
G
reen
(diluted
1:1,000),1

lof
C
andida
probe
(final
concentration,300
nM
),1

lof
tem
plate
D
N
A
(equivalent
to
20

lof
rinse
concentrate)
b
60
Initialdenaturation
at
95°C
for
15
s
and
then
95°C
for
0
s
62°C
for
2
s
74°C
for
2
s
a
T
he
reaction
m
ixtures
w
ere
50

lfor
the
IT
S-
and
N
18-specific
PC
R
s
and
10

lfor
the
L
ightC
ycler
PC
R
.T
aq
buffer
com
ponents,10
m
M
T
ris-H
C
l,50
m
M
K
C
l,0.1%
T
riton
X
-100
(pH
9.0).dN
T
P,deoxynucleoside
triphosphate.
b
A
ssum
ing
100%
D
N
A
extraction
efficiency.
VOL. 42, 2004 REAL-TIME PCR DETECTION OF CANDIDA 2103
 o
n
 February 25, 2014 by Cardiff Univ
http://jcm.asm.org/
D
ow
nloaded from
 
with both of these values being statistically significantly inferior
to those of the real-time assay (results not included). The
positive and negative predictive values were 83 and 92%, 69
and 81%, and 63 and 63% for the real-time PCR, the N18-
specific PCR, and the ITS-specific PCR, respectively.
Among the 91 culture-negative CRC samples, the real-time
PCR revealed that 20 were positive; this compares with 41 and
44 positive samples by the N18- and ITS-specific PCRs, respec-
tively. Thirty-two culture-negative CRC samples were negative
by all three PCRs. All three PCRs were positive for eight
culture-negative CRC samples, and a further 30 culture-nega-
tive CRC samples were positive by two of the three PCRs (Fig.
4).
Categorization of the culture-negative CRC samples into
clinical (n  60) and healthy control (n  31) groups shows
that only two (6%) samples from healthy controls that were
culture negative by CRC were positive by the real-time PCR.
In comparison, 18 (30%) culture-negative clinical CRC sam-
ples were positive by the real-time PCR. Eight (26%) culture-
negative CRC samples from healthy controls were N18-specific
PCR positive, and 33 (55%) of the culture-negative clinical
CRC samples were also N18-specific PCR positive. Analysis of
the ITS-specific PCR data revealed that 15 (48%) culture-
negative healthy control CRC samples were PCR positive, and
similar results were obtained for the culture-negative clinical
CRC samples, 29 (48%) of which were ITS-specific PCR pos-
itive (Fig. 3 and 4).
DISCUSSION
PCR for fungal detection has primarily been limited to re-
search laboratories but has recently been introduced into cer-
tain diagnostic mycology laboratories, especially in cases of
possible fungemia, where rapid diagnosis is a necessity and
culture from blood has proven problematic (5). Since PCRs are
gradually being integrated alongside standard laboratory meth-
ods, it was thought that it would be of benefit to assess specific
PCRs for candidal detection in CRC samples.
FIG. 1. Real-time PCR melting curve showing a positive sample (top) and a negative sample (bottom). The first peak indicates probe melting,
and the second peak indicates amplicon melting.
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Initial studies with spiked CRC samples indicated a real-
time PCR detection sensitivity of 1 to 10 yeasts/ml for C.
albicans, C. parapsilosis, C. tropicalis, and C. viswanathii. The
detection levels were lower for other Candida species (C. dub-
liniensis, C. glabrata, C. kefyr, and C. inconspicua). The Candi-
da-specific probe did not hybridize to amplicons from C. guil-
liermondii or C. famata, a finding that was in agreement with
our previous assessment of the PCR with blood samples (18).
The Candida-specific probe had originally been designed for
the detection of Candida in patients with candidemia, a con-
dition that is primarily attributed to C. albicans and, to a lesser
extent, C. tropicalis, C. parapsilosis, C. glabrata, and C. krusei
(18). Modification of the probe to enable detection of C. guil-
FIG. 2. Products obtained by N18-specific PCR for diluted suspen-
sions with 100 to 106 C. albicans (a) and C. dubiniensis (b) yeasts/ml.
FIG. 3. Percent agreement of PCR and culture.
FIG. 4. Agreement between negative culture and PCR results.
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liermondii and C. famata is possible, although the significance
of these two species in oral candidosis remains uncertain. Hav-
ing established that the real-time PCR methodology was ap-
plicable to these spiked control oral samples, the performance
of the PCR was determined with 193 CRC samples. Forty-
eight of these CRC samples were from individuals considered
free of oral candidosis. These samples were included to ensure
that an increased sensitivity of detection by real-time PCR
would not result in the production of large numbers of false-
positive (clinically insignificant) results. This situation would
have negated the value of the PCR as a suitable clinical test;
however, the results show that the real-time PCR and the gold
standard culture produced comparable results for our healthy
population.
Culture of the 145 clinical CRC samples from patients with
a variety of oral signs and symptoms revealed that 85 were
positive for Candida, representing a colonization rate of 59%.
This value was noticeably higher than the 35% carriage rate for
the 48 CRC samples from healthy mouths (17 positive sam-
ples), which compares favorably with the 36.8% rate published
by Abu-Elteen and Abu-Alteen (1). In the case of candidal
presence from patients with various disease states, the higher
incidence observed was expected, although comparison with
other studies is problematic due to the diversity of patient
groups. The overall incidence of C. albicans in the 102 culture-
positive CRC samples was 87%. This high incidence of C.
albicans relative to those of the other species concurs with
most studies of the candidal epidemiology of the mouth (6, 8).
An interesting observation from the culture data was the ap-
parent high incidence (compared with that in the healthy
mouths) of Candida in oral conditions not primarily associated
with the yeasts. This observation was particularly evident for
patients with lichen planus, burning mouth syndrome, and dry
mouth. The significance of Candida in these cases is uncertain,
but the altered oral state in these patients may, in part, offer an
environment more favorable to candidal colonization. Similar
high incidences of Candida from the mouths of individuals with
leukoplakia (82%), lichen planus (47%), and burning mouth
syndrome have been reported (6, 7).
Overall, the real-time PCR compared favorably with culture,
with the results of the real-time PCR achieving 94% agreement
with those of culture for the culture-positive samples. The six
samples with false-negative results were all non-C. albicans by
culture, and therefore, the results probably relate to the failure
of the probe to hybridize to the amplicon. Conversely, 20
real-time PCR-positive samples (18 clinical CRC samples and
2 healthy control CRC samples) were detected among the 91
culture-negative CRC samples, possibly highlighting the higher
sensitivity of real-time PCR (1 to 10 yeasts/ml) compared with
that of CRC (20 CFU/ml of concentrate). In addition, the
PCR approach was not reliant on the presence of viable or-
ganisms, thereby further enhancing its relative sensitivity over
culture. Fifteen of the 20 real-time PCR-positive, culture-neg-
ative samples were positive by at least one other PCR, and 8
culture-negative CRC samples were positive by all PCR meth-
ods. These findings accentuate the failure of culture to detect
Candida in certain oral samples.
Both block-based PCRs produced more than double the
number of culture-negative, PCR-positive results for CRC
samples than real-time PCR, although the clinical significance
of these results is uncertain. Dividing the culture-negative
CRC samples into clinical and healthy control CRC samples
reveals that the percentage of PCR-positive samples among
the healthy control samples was much higher for the block-
based PCRs (N18-specific PCR, 26%; ITS-specific PCR, 48%)
than for the real-time PCR (6%). If culture is considered the
gold standard, these findings could raise a question over the
clinical relevance of block-based PCR-positive results for cul-
ture-negative samples.
As the number of N18-specific PCR-positive samples was
greater than the number of culture-positive samples for both
the healthy control and clinical populations but the 95% con-
fidence intervals were approximately the same for both popu-
lations (2 to 26% for healthy controls, 4 to 24% for the clinical
cases), the clinical significance of the additional N18-specific
PCR-positive clinical samples is ambiguous. Conversely, as the
real-time PCR detected Candida in only 6% of the culture-
negative healthy control CRC samples (i.e., it did not produce
large numbers of false-positive, clinically irrelevant results),
the rise to a 30% rate of detection for the clinical (symptom-
atic) group is of interest. This is confirmed by the 95% confi-
dence intervals, which determined that the number of healthy
control samples positive by real-time PCR was not statistically
different from the number of the healthy control samples pos-
itive by culture (95% confidence interval, 11 to3%), whereas
the number of additional clinical samples positive by real-time
PCR was 2 to 15% greater (95% confidence intervals) than the
number of clinical samples positive by culture, and as such, the
results for the samples could be considered true positive.
The lower specificities of the block-based PCR methods over
that of real-time PCR could, in part, account for the increased
incidence of positive results by the block-based PCRs. Since
our experiments with spiked samples confirmed the overall
greater sensitivity of real-time PCR than other molecular
methods, it was likely that specificity largely contributed to the
increased numbers of block-based PCR-positive samples.
However, different PCR conditions and template volumes may
also have had an effect. Determination of whether the results
for block-based PCR-positive, culture-negative CRC samples
were true positive or false positive would require additional
testing, such as sequencing or restriction fragment length poly-
morphism analysis (21, 22, 23), thus increasing the complexity,
cost, and time required to obtain an assay result.
The question about the significance of culture-negative CRC
samples and clinical relevance needs to be raised, particularly
when positive results are evident by real-time PCR. It has been
suggested that the presence of elevated numbers of Candida
organisms indicates infection rather then normal commensal
carriage (9). However, Candida levels up to 9  103 CFU/ml
were evident in healthy controls in our studies, and on occa-
sion, these levels were higher than those in patients with oral
candidosis (data not shown). In patients with CHC, hyphal
penetration of the oral mucosa occurs, and in these patients
low numbers of yeasts may be recoverable from the mucosal
surface (17). The value of culture in patients with CHC may
therefore be limited, particularly if CRC is used for yeast
isolation. Furthermore, when patients have received antifungal
therapy the candidal load may be significantly reduced but
not eradicated, partly explaining the high recurrence of oral
candidosis among certain patients (19). In these circum-
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stances the improved sensitivity of real-time PCR would be
advantageous.
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